Next Financial Group’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$13K Buy
1,813
+1,555
+603% +$9.66K ﹤0.01% 2093
2021
Q3
$1K Buy
258
+26
+11% +$150 ﹤0.01% 2711
2021
Q2
$2K Hold
232
﹤0.01% 2465
2021
Q1
$2K Sell
232
-47
-17% -$384 ﹤0.01% 2349
2020
Q4
$2K Sell
279
-99
-26% -$577 ﹤0.01% 2228
2020
Q3
$1K Buy
+378
New +$1.53K ﹤0.01% 2159
2020
Q2
Sell
-760
Closed -$3K 1988
2020
Q1
$3K Buy
760
+193
+34% +$844 ﹤0.01% 1877
2019
Q4
$3K Buy
567
+76
+15% +$258 ﹤0.01% 2120
2019
Q3
$1K Buy
491
+252
+105% +$669 ﹤0.01% 2275
2019
Q2
$1K Sell
239
-62
-21% -$147 ﹤0.01% 2271
2019
Q1
$1K Buy
+301
New +$1.3K ﹤0.01% 1600
2018
Q4
Sell
-9
Closed 2128
2018
Q3
$0 Buy
+9
New +$87 ﹤0.01% 1530
2017
Q4
Sell
-14
Closed 1501
2017
Q3
$0 Buy
+14
New +$93 ﹤0.01% 1984
2017
Q1
Sell
-1,000
Closed -$2K 2353
2016
Q4
$2K Hold
1,000
﹤0.01% 2205
2016
Q3
$3K Buy
+1,000
New +$2.91K ﹤0.01% 2108
2014
Q4
Sell
-3,000
Closed -$32K 2420
2014
Q3
$32K Buy
+3,000
New +$33.9K 0.01% 1184

Other funds holding IMGN

Next Financial Group's IMGN Position: Q4 2021 in Review

Next Financial Group increased its Immunogen Inc (IMGN) stake by 603% in Q4 2021, buying an estimated $9.66K and bringing the position to 1,813 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2093.

Next Financial Group first reported a position in IMGN in Q3 2014 and has held it in 16 quarters since. The position peaked at $32K in Q3 2014. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

  • Next Financial Group held 1,813 shares of Immunogen Inc worth $13K as of Q4 2021.
  • Next Financial Group bought 1,555 Immunogen Inc shares in Q4 2021, an estimated $9.66K.
  • Immunogen Inc made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2093 holding.
  • Next Financial Group first reported a position in Immunogen Inc in Q3 2014 and has held it in 16 quarters since.
  • Next Financial Group's Immunogen Inc position peaked at $32K in Q3 2014.
  • 236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.